NEW YORK, NY — As October marks Breast Cancer Awareness Month, the familiar landscape of pink ribbons often dominates public discourse. However, for a significant and underserved community, this month represents something far more urgent than early detection. On October 13, National Metastatic Breast Cancer Awareness Day, a global movement will transcend mere awareness, turning the night sky into a beacon of hope and a call to action.
More than 325 landmarks across 20 countries, 195 cities, and all 50 U.S. states will illuminate in the signature colors of the metastatic breast cancer (MBC) movement—teal, green, and pink. The initiative, #LightUpMBC, is more than a visual spectacle; it is a critical fundraising engine designed to bridge the gap between terminal prognosis and survivable reality.
The Reality of Stage 4: What is Metastatic Breast Cancer?
To understand the urgency behind the #LightUpMBC campaign, one must first confront the stark realities of metastatic breast cancer. Often referred to as Stage 4, MBC occurs when cancer cells spread from the primary site in the breast to distant organs, most commonly the bones, liver, lungs, or brain.
Crucially, it remains breast cancer regardless of where it resides in the body. While many patients are diagnosed at Stage 4 from the outset, others may develop metastatic disease months, years, or even decades after completing treatment for earlier-stage breast cancer. For these patients, the journey is not a sprint with a finish line; it is a marathon of ongoing, lifelong treatment.
"Even when scans show no evidence of disease, that does not mean the cancer has been cured," explains the medical community. Treatment for MBC is palliative by nature—it aims to control the disease, extend life, and preserve the highest possible quality of life. Because cancer cells frequently develop resistance to therapies, patients are often forced to endure a grueling cycle of switching treatments, each with its own set of debilitating side effects.
Chronology of a Movement: From Local Tribute to Global Beacon
The origins of #LightUpMBC are rooted in personal loss and the desire for change. The campaign was founded by Laura Inahara, whose best friend, Jessica Moore, passed away from metastatic breast cancer at the age of 36.
"Jessica hoped to illuminate one local landmark," Inahara reflects. "Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research."
The progression of the campaign has been rapid:
- 2017: The movement begins with the illumination of Portsmouth’s Memorial Bridge in New Hampshire.
- 2020–2025: The campaign expands rapidly, gaining international recognition as cities across Europe, Asia, and North America join the initiative.
- October 13, 2026: The largest iteration to date, with over 325 landmarks participating, including iconic structures such as One World Trade Center in New York City, the Willis Tower in Chicago, Philadelphia City Hall, Niagara Falls, and the Mactan-Cebu Airport in the Philippines.
This growth reflects a shifting tide in how the public perceives breast cancer. While general awareness campaigns focus on the efficacy of mammograms, #LightUpMBC focuses on the "missing" conversation: that 42,670 people in the United States alone are projected to lose their lives to breast cancer in 2026. That is approximately 117 people every single day.
Supporting Data: The Case for Targeted Research
The necessity of the #LightUpMBC campaign is backed by cold, hard data. While advancements in early-stage breast cancer treatment have been significant, the outcomes for those with metastatic disease have not kept pace. METAvivor Research and Support, the organization driving this initiative, operates on a simple but radical premise: it exclusively funds Stage 4 metastatic breast cancer research.
The funding process is rigorous, utilizing a scientific peer and patient advocate review board to ensure that every dollar goes toward projects with the highest potential to change the trajectory of the disease.
Why is this necessary? Because conventional funding often favors early-stage research, which has a higher statistical likelihood of "success" in terms of cure rates. However, for the patient living with MBC, success is defined differently. They require treatments that can turn a terminal diagnosis into a chronic, manageable condition. By focusing exclusively on Stage 4, METAvivor is filling a critical void in the medical research landscape, providing hope to those who are currently living with the disease and those who will be diagnosed in the future.
Official Responses and Voices of Experience
The leadership at METAvivor emphasizes that the campaign is as much about community as it is about science. Dr. Kelly Shanahan, the Board President of METAvivor, speaks from the dual perspective of a physician and a patient.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan shared. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
This sentiment is echoed by the organizers of the #LightUpMBC Live event, a centerpiece of the October 13th awareness day. The event will be hosted by Tami Eagle Bowling, who has been living with MBC for 11 years, and Broadway performer and breast cancer survivor Kara Lindsay. Their participation underscores the intersection of patient advocacy and the arts, bringing a human face to the statistical data.
The livestream, which serves as an educational and musical tribute, will feature a lineup of performers including Tony Award winner Victoria Clark, Dorian Harewood, Christina Bianco, Cassandra Kubinski, and Tony Daniels. By blending high-profile entertainment with deep-dive scientific perspectives and raw patient narratives, the event aims to reach a global audience that may have previously overlooked the specific needs of the MBC community.
Implications: Transforming the Future of MBC
The implications of #LightUpMBC go beyond the one-night spectacle of illuminated monuments. The campaign serves as a powerful instrument for policy advocacy and public education.
1. Reframing the Narrative
For too long, the narrative surrounding breast cancer has been defined by the "survivor" trope—the woman who catches it early, undergoes treatment, and is declared "cured." While this is a wonderful outcome, it alienates the MBC community. #LightUpMBC forces the public to recognize that there is a subset of patients for whom "survivorship" means living with a terminal illness, not being cured of it.
2. Economic and Scientific Impact
By raising over $2.7 million in previous years, the campaign has directly financed clinical trials and laboratory studies that might otherwise have gone unfunded. This capitalizes on the idea of "patient-led research," where the priorities of the individuals suffering from the disease dictate the direction of the science.
3. Strengthening Patient Advocacy
The campaign provides a platform for patients to share their stories. For a patient with MBC, the psychological burden of a terminal diagnosis is heavy. By seeing their local landmarks lit up in their honor, and by hearing from others in similar positions during the #LightUpMBC Live broadcast, patients are empowered to stop viewing themselves as statistics and start viewing themselves as active participants in the fight for their own lives.
How to Get Involved
The organizers are calling on the public to participate in the movement by:
- Visiting Landmarks: The public is encouraged to visit participating landmarks, take photographs, and share them on social media using the hashtags #LightUpMBC and #METAVIVOR, tagging @LightUpMBC.
- Watching the Broadcast: The #LightUpMBC Live event will air on October 13 at 8 p.m. ET / 5 p.m. PT. It will be available for free on the METAvivor YouTube channel and Facebook Live, with additional streaming via LiveOne.
- Donating: One hundred percent of net proceeds from the campaign and the livestream will go directly toward METAvivor’s research grants.
As the sun sets on October 13, the glowing landmarks will stand as more than just architecture. They will serve as a global, synchronized testament that for the thousands living with metastatic breast cancer, the fight is far from over—and with the help of global support, a future where MBC is a survivable condition is within reach.
For more information, to see a full list of participating landmarks, or to donate, visit www.lightupmbc.org.
About the Author
